1
|
Papp KV, Rofael H, Veroff AE, Donohue MC, Wang S, Randolph C, Grober E, Brashear HR, Novak G, Ernstrom K, Raman R, Aisen PS, Sperling R, Romano G, Henley D. Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial. J Prev Alzheimers Dis 2022; 9:255-261. [PMID: 35542998 DOI: 10.14283/jpad.2022.17] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
BACKGROUND Cognitive composites commonly serve as primary outcomes in Alzheimer's disease (AD) secondary prevention trials. OBJECTIVE To evaluate the association between amyloid (Aβ) burden level (+/-) and performance on three separate composite endpoints: Preclinical Alzheimer's Cognitive Composite (PACC), PACC+Semantic Fluency (PACC5), and Repeatable Battery for Neuropsychological Status (RBANS). DESIGN Screening data from the randomized, double-blind, placebo-controlled, phase 2b/3 atabecestat EARLY study in preclinical AD participants were used in this analysis. SETTING The EARLY study was conducted at 143 centers across 14 countries. PARTICIPANTS 3,569 cognitively unimpaired older adults (Clinical Dementia Rating of 0; aged 60-85 years) screened for inclusion in the EARLY study with Aβ status and at least PACC or RBANS at screening were included. Participants were categorized as those with non-pathological Aβ levels (Aβ-, n=2,824) and those with pathological Aβ levels (Aβ+, n=745) based on florbetapir uptake or levels of cerebrospinal fluid Aβ1-42. MEASUREMENTS Analysis of Covariance models controlling for age, sex, and education were used to examine the difference in PACC, PACC5, and RBANS between Aβ groups. Nonparametric bootstrap was used to compare sensitivity of composites to differentiate between Aβ status. RESULTS Of 3,569 participants, 2,116 were women (59%); 3,006 were Caucasian (84%); mean (SD) age was 68.98 (5.28) years. Aβ+ participants performed worse versus Aβ- participants on all cognitive composites though the magnitude of the Aβ effect was generally small. The Aβ+/- effect size for the PACC (Cohen's d=-0.15) was significantly greater than the RBANS (d=-0.097) while the PACC5 effect size (d=-0.139) was numerically larger than the RBANS. When examining subscores from the composites, memory tests (i.e., Free and Cued Selective Reminding Test, Figure Recall) and speed of processing (i.e., Digit-Symbol/Coding on the PACC/RBANS) exhibited the largest Aβ+/- effect sizes. CONCLUSIONS Cross-sectional relationships between Aβ and cognition among clinically unimpaired older adults are detectable on multi-domain cognitive composites but are relatively small in magnitude. The Aβ+/- group effect was statistically larger for PACC and marginally larger for PACC5 versus RBANS. However, interpretation of composite sensitivity to Aβ status cross-sectionally cannot be generalized to sensitivity to change over time.
Collapse
Affiliation(s)
- K V Papp
- Kathryn V. Papp, PhD, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, 60 Fenwood Road, Boston, MA 02115; Tel: +1 617-643-5322; E-mail:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Papp KV, Rentz DM, Winskill C, Betensky RA, Amariglio RE, Schultz AP, Johnson KA, Sperling RA. Associations between biomarker status (amyloid, tau) and risk for progression to MCI/Dementia in the Harvard Aging Brain Study. Alzheimers Dement 2021. [DOI: 10.1002/alz.056231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Kate V. Papp
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| | - Dorene M. Rentz
- Center for Alzheimer’s Research and Treatment Department of Neurology Brigham and Women’s Hospital Harvard Medical School Boston MA USA
| | | | | | | | - Aaron P. Schultz
- Massachusetts General Hospital Harvard Medical School Department of Neurology Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Center for Alzheimer’s Research and Treatment Department of Neurology Brigham and Women’s Hospital Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Center for Alzheimer’s Research and Treatment Department of Neurology Brigham and Women’s Hospital Harvard Medical School Boston MA USA
| |
Collapse
|
3
|
Papp KV, Rentz DM, Buckley RF, Schneider OR, Hsieh S, Soberanes D, Properzi MJ, Schultz AP, Johnson KA, Sperling RA, Amariglio RE. Associations between remote cognitive testing on an individual’s own digital device and amyloid burden on neuroimaging in clinically normal older adults: Results from Boston Remote Assessment for Neurocognitive Health (BRANCH). Alzheimers Dement 2021. [DOI: 10.1002/alz.056209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Kate V. Papp
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Dorene M. Rentz
- Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | | | | | | | | | | | | | - Keith A. Johnson
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | | |
Collapse
|
4
|
Farrell ME, Papp KV, Buckley RF, Jacobs HI, Schultz AP, Properzi MJ, Vannini P, Hanseeuw B, Rentz DM, Johnson KA, Sperling RA. Sequential early cognitive changes sensitive to rising beta‐amyloid and tau pathology in preclinical AD. Alzheimers Dement 2021. [DOI: 10.1002/alz.056315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
| | - Kate V. Papp
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Rachel F. Buckley
- Massachusetts General Hospital/Harvard Medical School Boston MA USA
- The Florey Institute of Neuroscience and Mental Health Parkville Australia
| | - Heidi I.L. Jacobs
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Maastricht University Maastricht Netherlands
| | - Aaron P Schultz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Patrizia Vannini
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Bernard Hanseeuw
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Institute of Neuroscience, Université Catholique de Louvain Brussels Belgium
| | - Dorene M. Rentz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| |
Collapse
|
5
|
Baker LD, Espeland MA, Whitmer RA, Kivipelto M, Antkowiak S, Chavin M, Cleveland M, Correia S, Day CE, Elbein R, Farias ST, Gitelman DR, Graef S, Katula JA, Lambert K, Leng XI, Lovato L, Morris MC, Ngandu T, Papp KV, Pavlik V, Raman R, Robertson J, Rushing S, Salloway SP, Solomon A, Tangney CC, Ventrelle J, Williams BJ, Williamson JD, Wilmoth S, Wing RR, Woolard N, Yu M, Snyder HM, Carrillo MC. U.S. POINTER: Lessons learned about delivery of a multi‐domain lifestyle intervention during the COVID‐19 pandemic. Alzheimers Dement 2021. [PMCID: PMC9011466 DOI: 10.1002/alz.055289] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Background U.S. POINTER is testing whether multidomain lifestyle interventions focused on physical exercise, nutrition, cognitive challenge, and risk factor management reduces risk of cognitive decline in a heterogeneous population of at‐risk older adults in America. The study adapts the FINGER (Finnish Intervention Geriatric Study to Prevent Cognitive Impairment and Disability) interventions to fit the United States culture and delivers the intervention within the community at 5 sites across the country. Method U.S. POINTER is a 2‐year RCT that will enroll 2000 cognitively unimpaired older adults who are at risk for cognitive decline due sedentary lifestyle, poor diet and other factors. Participants are randomized to one of two lifestyle intervention groups that differ in format and intensity. In 2020, the COVID‐19 pandemic presented a number of challenges for the study that affected recruitment, assessment schedules, and intervention delivery. Result As of March 2020, when COVID‐19 incidence was on an exponential rise in the US, 240 participants had been enrolled in U.S. POINTER. In response to local and national safety mandates, study activities were paused from March 23rd to July 13th. During the pause, sites remained in contact with study candidates and enrolled participants to provide ongoing support to keep them engaged in the trial. Enrollees also received regular telephone calls to encourage continued adherence to their assigned lifestyle intervention. In response to the multiple pandemic‐related challenges, study protocols and procedures were adapted to facilitate and encourage participant adherence to intervention activities. At study re‐start, retention was 98%. Despite climbing COVID‐19 infection rates nationwide, enrollment at all 5 sites has continued at a steady rate (N=540 as of Jan2021), virtual Team Meeting attendance for both lifestyle groups exceeds 80%, and participants continue to successfully work toward their intervention goals. Conclusion The COVID‐19 pandemic presented unprecedented challenges, but it also provided a unique opportunity to adapt intervention delivery so that a nonpharmacological community‐based trial could continue – even during a debilitating global health crisis. U.S. POINTER’s adaptations to pandemic‐related challenges may ultimately increase the resilience of its interventions to even the most challenging of circumstances that older adults will face now and in the future.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Stephen Correia
- Butler Hospital Providence RI USA
- Brown University Providence RI USA
| | | | | | | | | | | | | | | | | | - Laura Lovato
- Wake Forest School of Medicine Winston‐Salem NC USA
| | | | | | - Kate V Papp
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | | | - Rema Raman
- Alzheimer's Therapeutic Research Institute, University of Southern California San Diego CA USA
| | | | | | - Stephen P Salloway
- Butler Hospital Providence RI USA
- Alpert Medical School of Brown University Providence RI USA
| | | | | | | | | | | | | | | | | | - Melissa Yu
- Baylor College of Medicine Houston TX USA
| | | | | | | |
Collapse
|
6
|
Jutten RJ, Amariglio RE, Properzi MJ, Buckley RF, Maruff PT, Stark CE, Yassa MA, Johnson KA, Sperling RA, Rentz DM, Papp KV. Monthly computerized at‐home assessments to detect cognitive change in preclinical Alzheimer’s disease. Alzheimers Dement 2021. [DOI: 10.1002/alz.056055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Roos J. Jutten
- Massachusetts General Hospital Boston MA USA
- Harvard Medical School Boston MA USA
| | - Rebecca E. Amariglio
- Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Michael J Properzi
- Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Rachel F. Buckley
- Harvard Medical School Boston MA USA
- Massachusetts General Hospital/Harvard Medical School Boston MA USA
- Melbourne School of Psychological Sciences, University of Melbourne Melbourne VIC Australia
| | - Paul T Maruff
- Cogstate Ltd. Melbourne VIC Australia
- The Florey Institute of Neuroscience and Mental Health Melbourne VIC Australia
| | | | | | - Keith A. Johnson
- Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Boston MA USA
| | - Dorene M. Rentz
- Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Kate V. Papp
- Massachusetts General Hospital Boston MA USA
- Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Boston MA USA
| |
Collapse
|
7
|
Rodriguez‐Vieitez E, Montal V, Sepulcre J, Lois C, Hanseeuw B, Vilaplana E, Schultz AP, Properzi MJ, Scott MR, Amariglio RE, Papp KV, Marshall GA, Fortea J, Johnson KA, Sperling RA, Vannini P. Cortical microstructure is associated with tau burden and predicts cognitive decline and clinical progression in healthy older adults. Alzheimers Dement 2021. [DOI: 10.1002/alz.053011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Elena Rodriguez‐Vieitez
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Karolinska Institutet Stockholm Sweden
| | - Victor Montal
- CIBERNED Network Center for Biomedical Research in Neurodegenerative Diseases National Institute of Health Carlos III Madrid Spain
- Sant Pau Memory Unit Hospital de la Santa Creu i Sant Pau‐Biomedical Research Institute Sant Pau‐Universitat Autònoma de Barcelona Barcelona Spain
| | - Jorge Sepulcre
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging Boston MA USA
| | - Cristina Lois
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging Boston MA USA
| | - Bernard Hanseeuw
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging Boston MA USA
- Saint Luc University Hospital Université Catholique de Louvain Brussels Belgium
| | - Eduard Vilaplana
- CIBERNED Network Center for Biomedical Research in Neurodegenerative Diseases National Institute of Health Carlos III Madrid Spain
- Sant Pau Memory Unit Hospital de la Santa Creu i Sant Pau‐Biomedical Research Institute Sant Pau‐Universitat Autònoma de Barcelona Barcelona Spain
| | - Aaron P. Schultz
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Michael J Properzi
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Matthew R. Scott
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Rebecca E. Amariglio
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| | - Kate V. Papp
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| | - Gad A Marshall
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| | - Juan Fortea
- CIBERNED Network Center for Biomedical Research in Neurodegenerative Diseases National Institute of Health Carlos III Madrid Spain
- Sant Pau Memory Unit Hospital de la Santa Creu i Sant Pau‐Biomedical Research Institute Sant Pau‐Universitat Autònoma de Barcelona Barcelona Spain
| | - Keith A. Johnson
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging Boston MA USA
| | - Reisa A. Sperling
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| | - Patrizia Vannini
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| |
Collapse
|
8
|
Jacobs HI, Becker A, Kwong K, Engels N, Prokopiou PC, Papp KV, Properzi MJ, Hampton OL, Sanchez JS, Rentz DM, Fakhri GE, Normandin MD, Bennett DA, Sperling RA, Johnson KA. Locus coeruleus integrity as a proxy of initial tau burden: in vivo versus ex vivo observations. Alzheimers Dement 2021. [DOI: 10.1002/alz.056391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Heidi I.L. Jacobs
- Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University Maastricht Netherlands
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Faculty of Health, Medicine and Life Sciences, Maastricht University Maastricht Netherlands
| | - Alex Becker
- Massachusetts General Hospital Boston MA USA
| | - Kenneth Kwong
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Nina Engels
- Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Massachusetts General Hospital Charlestown MA USA
| | | | - Kate V. Papp
- Massachusetts General Hospital Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | | | - Olivia L. Hampton
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Dorene M. Rentz
- Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | | | | | - David A. Bennett
- Rush Alzheimer’s Disease Center and Department of Neurological Sciences, Rush University Medical Center Chicago IL USA
| | - Reisa A. Sperling
- Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging Boston MA USA
| |
Collapse
|
9
|
Papp KV, Rentz DM, Maruff P, Sun CK, Raman R, Donohue MC, Schembri A, Stark C, Yassa MA, Wessels AM, Yaari R, Holdridge KC, Aisen PS, Sperling RA. The Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention Trial. J Prev Alzheimers Dis 2021; 8:59-67. [PMID: 33336226 PMCID: PMC7755110 DOI: 10.14283/jpad.2020.38] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/04/2022]
Abstract
BACKGROUND Computerized cognitive assessments may improve Alzheimer's disease (AD) secondary prevention trial efficiency and accuracy. However, they require validation against standard outcomes and relevant biomarkers. OBJECTIVE To assess the feasibility and validity of the tablet-based Computerized Cognitive Composite (C3). DESIGN Cross-sectional analysis of cognitive screening data from the A4 study (Anti-Amyloid in Asymptomatic AD). SETTING Multi-center international study. PARTICIPANTS Clinically normal (CN) older adults (65-85; n=4486). MEASUREMENTS Participants underwent florbetapir-Positron Emission Tomography for Aβ+/- classification. They completed the C3 and standard paper and pencil measures included in the Preclinical Alzheimer's Cognitive Composite (PACC). The C3 combines memory measures sensitive to change over time (Cogstate Brief Battery-One Card Learning) and measures shown to be declining early in AD including pattern separation (Behavioral Pattern Separation Test- Object- Lure Discrimination Index) and associative memory (Face Name Associative Memory Exam- Face-Name Matching). C3 acceptability and completion rates were assessed using qualitative and quantitative methods. C3 performance was explored in relation to Aβ+/- groups (n=1323/3163) and PACC. RESULTS C3 was feasible for CN older adults to complete. Rates of incomplete or invalid administrations were extremely low, even in the bottom quartile of cognitive performers (PACC). C3 was moderately correlated with PACC (r=0.39). Aβ+ performed worse on C3 compared with Aβ- [unadjusted Cohen's d=-0.22 (95%CI: -0.31,-0.13) p<0.001] and at a magnitude comparable to the PACC [d=-0.32 (95%CI: -0.41,-0.23) p<0.001]. Better C3 performance was observed in younger, more educated, and female participants. CONCLUSIONS These findings provide support for both the feasibility and validity of C3 and computerized cognitive outcomes more generally in AD secondary prevention trials.
Collapse
Affiliation(s)
- K V Papp
- Kathryn V. Papp, Center for Alzheimer Research and Treatment; 60 Fenwood Road; Boston, MA 02115, Telephone: 617-643-5322; Fax: 857-5461, Email Address:
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Rentz DM, Papp KV, Sperling RA, Souillard-Mandar W, Penney DL, Davis R, Johnson KA. F3-01-02: CAPTURING COGNITIVE IMPAIRMENT AT THE PRECLINICAL STAGE OF ALZHEIMER'S DISEASE USING DIGITAL TECHNOLOGY. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.4597] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- Dorene M. Rentz
- Massachusetts General Hospital; Boston MA USA
- Center for Alzheimer Research and Treatment; Brigham and Women's Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
| | - Kate V. Papp
- Brigham and Women's Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
- Center for Alzheimer Research and Treatment; Brigham and Women's Hospital; Boston MA USA
| | - Reisa A. Sperling
- Massachusetts General Hospital; Boston MA USA
- Center for Alzheimer Research and Treatment; Brigham and Women's Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
- Department of Neurology; Massachusetts General Hospital, Harvard Medical School; Boston MA USA
- Center for Alzheimer Research and Treatment; Brigham and Women's Hospital, Harvard Medical School; Boston MA USA
| | | | - Dana L. Penney
- Digital Cognition Technologies; Waltham MA USA
- Lahey Health; Burlington MA USA
| | - Randall Davis
- Digital Cognition Technologies; Waltham MA USA
- MIT Computer Science And Artificial Intelligence Laboratory; Cambridge MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
- Department of Radiology, Division of Molecular Imaging and Nuclear Medicine; Massachusetts General Hospital; Boston MA USA
| |
Collapse
|
11
|
Baker LD, Beavers DP, Cleveland M, Day CE, Decarli C, Espeland MA, Tomaszewski-Farias SE, Jimenez-Maggiora G, Katula J, Kivipelto M, Lambert K, Leng XI, Morris MC, Ngandu T, Papp KV, Raman R, Robertson J, Rushing S, Snyder HM, Solomon A, Su J, Ventrelle J, Williams B, Williamson JD, Whitmer RA, Woolard N, Carrillo MC. O4-11-03: U.S. POINTER: STUDY DESIGN AND LAUNCH. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.4802] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Laura D. Baker
- Wake Forest School of Medicine; Winston-Salem NC USA
- Wake Forest University Health Sciences; Winston Salem NC USA
| | | | | | | | - Charles Decarli
- IDeA Laboratory; Department of Neurology, UC Davis; Davis CA USA
| | | | | | | | - Jeff Katula
- Wake Forest School of Medicine; Winston Salem NC USA
| | - Miia Kivipelto
- Kuopio University Hospital; Kuopio Finland
- Division of Clinical Geriatrics; Karolinska Institutet; Stockholm Sweden
- Institute of Clinical Medicine/Neurology; University of Eastern Finland; Kuopio Finland
- National Institute for Health and Welfare; Helsinki Finland
| | | | | | | | - Tiia Ngandu
- National Institute for Health and Welfare; Helsinki Finland
- Karolinska Institutet Center for Alzheimer Research; Stockholm Sweden
| | - Kate V. Papp
- Center for Alzheimer Research and Treatment; Brigham and Womens Hospital, Harvard Medical School; Boston MA USA
- Harvard Medical School; Boston MA USA
- Massachusetts General Hospital; Boston MA USA
| | - Rema Raman
- University of Southern California; San Diego CA USA
| | | | - Scott Rushing
- Wake Forest School of Medicine; Winston-Salem NC USA
| | | | - Alina Solomon
- Institute of Clinical Medicine; Kuopio Finland
- University of Eastern Finland; Kuopio Finland
| | - Jing Su
- Wake Forest School of Medicine; Winston-Salem NC USA
| | | | | | | | | | - Nancy Woolard
- Wake Forest School of Medicine; Winston-Salem NC USA
| | | |
Collapse
|
12
|
Jutten RJ, Sikkes SA, Amariglio R, Buckley RF, Properzi MJ, Marshall GA, Rentz DM, Johnson KA, van der Flier WM, Scheltens P, Sperling RA, Papp KV. F2-03-02: OPTIMIZING COGNITIVE OUTCOMES FOR BIOMARKER POSITIVE INDIVIDUALS AT DIFFERENT CLINICAL STAGES OF ALZHEIMER'S DISEASE ACCORDING TO THE NIA-AA RESEARCH FRAMEWORK. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.4425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Roos J. Jutten
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
| | - Sietske A.M. Sikkes
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
- Harvard Medical School; Boston MA USA
- Massachusetts General Hospital; Boston MA USA
| | - Rebecca Amariglio
- Harvard Medical School; Boston MA USA
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
| | - Rachel F. Buckley
- Harvard Medical School; Boston MA USA
- Massachusetts General Hospital; Boston MA USA
| | | | - Gad A. Marshall
- Harvard Medical School; Boston MA USA
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
| | - Dorene M. Rentz
- Harvard Medical School; Boston MA USA
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
| | - Keith A. Johnson
- Harvard Medical School; Boston MA USA
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
| | - Wiesje M. van der Flier
- Alzheimer center Amsterdam, Department of Neurology, Amsterdam Neuroscience; VU University Medical Center, Amsterdam UMC; Amsterdam Netherlands
| | - Philip Scheltens
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
| | - Reisa A. Sperling
- Harvard Medical School; Boston MA USA
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
| | - Kate V. Papp
- Harvard Medical School; Boston MA USA
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
| |
Collapse
|
13
|
Manning LK, Papp KV, Hampton O, Scott MR, Uquillas FD, Jiang S, Rentz DM, Johnson KA, Sperling RA, Schultz AP. P3-349: ASSOCIATIONS OF REGIONAL CORTICAL THINNING AND LONGITUDINAL COGNITIVE PERFORMANCE IN THE CONTEXT OF AMYLOID IN CLINICALLY NORMAL OLDER ADULTS. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.3381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- Lyssa K. Manning
- Massachusetts General Hospital; Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging; Boston MA USA
| | - Kate V. Papp
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
| | | | - Matthew R. Scott
- Massachusetts General Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging; Charlestown MA USA
| | | | - Shu Jiang
- Massachusetts General Hospital; Boston MA USA
| | - Dorene M. Rentz
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging; Charlestown MA USA
| | - Reisa A. Sperling
- Massachusetts General Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging; Charlestown MA USA
- Brigham and Women's Hospital; Boston MA USA
| | - Aaron P. Schultz
- Massachusetts General Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging; Charlestown MA USA
| |
Collapse
|
14
|
Papp KV, Buckley RF, Mormino EC, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio R. P3-031: CLINICAL MEANINGFULNESS OF SHORT-TERM COGNITIVE DECLINE ON THE PRECLINICAL ALZHEIMER'S COGNITIVE COMPOSITE-5 (PACC-5) IN NORMAL OLDER ADULTS WITH ELEVATED β-AMYLOID. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.3057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- Kate V. Papp
- Harvard Medical School; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
- Massachusetts General Hospital; Boston MA USA
| | | | | | - Paul Maruff
- Cogstate Ltd.; Melbourne Australia
- The Florey Institute of Neuroscience and Mental Health; Melbourne Australia
| | | | | | | | | | | | - Rebecca Amariglio
- Brigham and Women's Hospital; Boston MA USA
- Massachusetts General Hospital; Boston MA USA
| |
Collapse
|
15
|
Manning LK, Papp KV, Hampton O, Scott MR, Uquillas FD, Jiang S, Rentz DM, Johnson KA, Sperling RA, Schultz AP. IC-P-089: ASSOCIATIONS OF REGIONAL CORTICAL THINNING AND LONGITUDINAL COGNITIVE PERFORMANCE IN THE CONTEXT OF AMYLOID IN CLINICALLY NORMAL OLDER ADULTS. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.4932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- Lyssa K. Manning
- Massachusetts General Hospital; Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging; Boston MA USA
| | - Kate V. Papp
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
| | | | - Matthew R. Scott
- Massachusetts General Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging; Charlestown MA USA
| | | | - Shu Jiang
- Massachusetts General Hospital; Boston MA USA
| | - Dorene M. Rentz
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital; Boston MA USA
- Brigham and Women's Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging; Charlestown MA USA
| | - Reisa A. Sperling
- Massachusetts General Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging; Charlestown MA USA
- Brigham and Women's Hospital; Boston MA USA
| | - Aaron P. Schultz
- Massachusetts General Hospital; Boston MA USA
- Harvard Medical School; Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging; Charlestown MA USA
| |
Collapse
|
16
|
Munro CE, Donovan NJ, Amariglio RE, Papp KV, Marshall GA, Rentz DM, Pascual-Leone A, Sperling RA, Locascio JJ, Vannini P. The Impact of Awareness of and Concern About Memory Performance on the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease Dementia. Am J Geriatr Psychiatry 2018; 26:896-904. [PMID: 29866588 PMCID: PMC6959130 DOI: 10.1016/j.jagp.2018.04.008] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/16/2018] [Revised: 04/27/2018] [Accepted: 04/30/2018] [Indexed: 11/19/2022]
Abstract
OBJECTIVE To investigate the relationship of awareness of and concern about memory performance to progression from mild cognitive impairment (MCI) to Alzheimer disease (AD) dementia. METHODS Participants (n = 33) had a diagnosis of MCI at baseline and a diagnosis of MCI or AD dementia at follow-up. Participants were categorized as "Stable-MCI" if they retained an MCI diagnosis at follow-up (mean follow-up = 18.0 months) or "Progressor-MCI" if they were diagnosed with AD dementia at follow-up (mean follow-up = 21.6 months). Awareness was measured using the residual from regressing a participant's objective memory score onto their subjective complaint score (i.e., residual<0 indicates overestimation of performance). Concern was assessed using a questionnaire examining the degree of concern when forgetting. Logistic regression was used to determine whether the presence of these syndromes could predict future diagnosis of AD dementia, and repeated measures analysis of covariance tests were used to examine longitudinal patterns of these syndromes. RESULTS Baseline anosognosia was apparent in the Progressor-MCI group, whereas participants in the Stable-MCI group demonstrated relative awareness of their memory performance. Baseline awareness scores successfully predicted whether an individual would progress to AD-dementia. Neither group showed change in awareness of performance over time. Neither group showed differences in concern about memory performance at baseline or change in concern about performance over time. CONCLUSION These data suggest that anosognosia may appear prior to the onset of AD dementia, while anosodiaphoria likely does not appear until later in the AD continuum. Additionally, neither group showed significant changes in awareness or concern over time, suggesting that change in these variables may happen over longer periods.
Collapse
Affiliation(s)
- Catherine E Munro
- Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital, Boston, MA
| | - Nancy J Donovan
- Harvard Medical School, Boston, MA; Center for Alzheimer Research and Treatment, Department of Neurology Brigham and Women's Hospital, Boston, MA; Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
| | - Rebecca E Amariglio
- Harvard Medical School, Boston, MA; Center for Alzheimer Research and Treatment, Department of Neurology Brigham and Women's Hospital, Boston, MA
| | - Kate V Papp
- Harvard Medical School, Boston, MA; Center for Alzheimer Research and Treatment, Department of Neurology Brigham and Women's Hospital, Boston, MA
| | - Gad A Marshall
- Harvard Medical School, Boston, MA; Center for Alzheimer Research and Treatment, Department of Neurology Brigham and Women's Hospital, Boston, MA; Athinoula A Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA
| | - Dorene M Rentz
- Harvard Medical School, Boston, MA; Center for Alzheimer Research and Treatment, Department of Neurology Brigham and Women's Hospital, Boston, MA
| | - Alvaro Pascual-Leone
- Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
| | - Reisa A Sperling
- Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA; Center for Alzheimer Research and Treatment, Department of Neurology Brigham and Women's Hospital, Boston, MA; Athinoula A Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA
| | - Joseph J Locascio
- Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA
| | - Patrizia Vannini
- Harvard Medical School, Boston, MA; Center for Alzheimer Research and Treatment, Department of Neurology Brigham and Women's Hospital, Boston, MA; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA.
| |
Collapse
|
17
|
Papp KV, Mormino BC, Huijbers W, Dickerson BC, Orlovsky I, Schultz AP, Sperling RA, Rentz DM, Johnson K. [O3–06–02]: SEMANTIC MEMORY AND PET AMYLOID AND TAU DEPOSITION IN PRECLINICAL AND PRODROMAL ALZHEIMER's DISEASE. Alzheimers Dement 2017. [DOI: 10.1016/j.jalz.2017.07.333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Kate V. Papp
- Massachusetts General HospitalBostonMAUSA
- Harvard Medical SchoolBostonMAUSA
- Brigham and Women's HospitalBostonMAUSA
- Stanford University School of MedicinePalo AltoCAUSA
- Tilburg UniversityTilburgNetherlands
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Mormino BC, Schultz AP, Papp KV, LaPoint MR, Hanseeuw BJ, Hedden T, Rentz DM, Sperling RA, Johnson K. [IC‐02–03]: TAU AND HIPPOCAMPAL VOLUME REFLECT DISTINCT PROCESSES IN PRECLINICAL ALZHEIMER's DISEASE. Alzheimers Dement 2017. [DOI: 10.1016/j.jalz.2017.06.2628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
| | - Aaron P. Schultz
- Athinoula A. Martinos Center for Biomedical ImagingCharlestownMAUSA
| | | | | | | | - Trey Hedden
- Athinoula A. Martinos Center for Biomedical ImagingCharlestownMAUSA
| | | | | | | |
Collapse
|
19
|
Buckley RF, Hanseeuw BJ, Schultz AP, Vannini P, Jackson JD, Papp KV, Mormino BC, Rentz DM, Sperling RA, Johnson K, Amariglio R. [O2–10–03]: SEVERITY OF SUBJECTIVE COGNITIVE DECLINE ALIGNS WITH REGIONAL AMYLOID SEVERITY: FINDINGS FROM THE HARVARD AGING BRAIN STUDY. Alzheimers Dement 2017. [DOI: 10.1016/j.jalz.2017.07.200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Rachel F. Buckley
- Massachusetts General HospitalCharlestownMAUSA
- University of MelbourneMelbourneAustralia
- The Florey Institute of Neuroscience and Mental HealthMelbourneAustralia
- Massachusetts General HospitalBostonMAUSA
- Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging, Harvard Medical SchoolBostonMAUSA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Hanseeuw BJ, Mormino BC, Becker A, Sepulcre J, Papp KV, Schultz AP, Jacobs HIL, Cosio DM, Chhatwal JP, Sperling RA, Johnson K. [IC‐P‐181]: LONGITUDINAL TAU ACCUMULATION IS ASSOCIATED WITH COGNITIVE DECLINE IN NORMAL ELDERLY. Alzheimers Dement 2017. [DOI: 10.1016/j.jalz.2017.06.2556] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Bernard J. Hanseeuw
- Massachusetts General HospitalBostonMAUSA
- Harvard Medical SchoolBostonMAUSA
- Institute of Neuroscience, Université Catholique de LouvainBrusselsBelgium
| | - Beth C. Mormino
- Massachusetts General HospitalBostonMAUSA
- Stanford University School of MedicinePalo AltoCAUSA
| | | | - Jorge Sepulcre
- Massachusetts General HospitalBostonMAUSA
- Harvard Medical SchoolBostonMAUSA
| | - Kate V. Papp
- Massachusetts General HospitalBostonMAUSA
- Harvard Medical SchoolBostonMAUSA
| | | | - Heidi IL. Jacobs
- Massachusetts General HospitalBostonMAUSA
- Alzheimer Center LimburgMaastricht UniversityMaastrichtNetherlands
| | - Danielle M. Cosio
- Massachusetts General HospitalBostonMAUSA
- Massachusetts Institute of TechnologyCambridgeMAUSA
| | | | - Reisa A. Sperling
- Massachusetts General HospitalBostonMAUSA
- Harvard Medical SchoolBostonMAUSA
- Center for Alzheimer Research and TreatmentBrigham and Women's Hospital, Harvard Medical SchoolBostonMAUSA
| | - Keith Johnson
- Massachusetts General HospitalBostonMAUSA
- Harvard Medical SchoolBostonMAUSA
| |
Collapse
|
21
|
Orlovsky I, Mormino BC, Huijbers W, Schultz AP, Rentz DM, Sperling RA, Johnson K, Papp KV. [O3–07–06]: THE RELATIONSHIP BETWEEN RECALL OF RECENTLY VERSUS REMOTELY ENCODED FAMOUS FACES AND AMYLOID AND TAU BURDEN IN CLINICALLY NORMAL OLDER ADULTS. Alzheimers Dement 2017. [DOI: 10.1016/j.jalz.2017.07.343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Irina Orlovsky
- Massachusetts General HospitalBostonMAUSA
- Tilburg UniversityTilburgNetherlands
- Massachusetts General HospitalCharlestownMAUSA
- Brigham and Women's HospitalBostonMAUSA
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Buckley RF, Sparks KP, Papp KV, Dekhtyar M, Martin C, Burnham S, Sperling RA, Rentz DM. Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries. J Prev Alzheimers Dis 2017; 4:3-11. [PMID: 29188853 PMCID: PMC5726304 DOI: 10.14283/jpad.2017.1] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
BACKGROUND As prevention trials for Alzheimer's disease move into asymptomatic populations, identifying older individuals who manifest the earliest cognitive signs of Alzheimer's disease is critical. Computerized cognitive testing has the potential to replace current gold standard paper and pencil measures and may be a more efficient means of assessing cognition. However, more empirical evidence about the comparability of novel computerized batteries to paper and pencil measures is required. OBJECTIVES To determine whether two computerized IPad batteries, the NIH Toolbox Cognition Battery and Cogstate-C3, similarly predict subtle cognitive impairment identified using the Preclinical Alzheimer Cognitive Composite (PACC). DESIGN, SETTING, PARTICIPANTS A pilot sample of 50 clinically normal older adults (Mage=68.5 years±7.6, 45% non-Caucasian) completed the PACC assessment, and the NIH Toolbox and Cogstate-C3 at research centers of Massachusetts General and Brigham and Women's Hospitals. Participants made 3-4 in-clinic visits, receiving the PACC first, then the NIH Toolbox, and finally the Cogstate-C3.>= 0.5SD), versus subtle cognitive impairment (<0.5SD). Composites for each computerized battery were created using principle components analysis, and compared with the PACC using non-parametric Spearman correlations. Logistic regression analyses were used to determine which composite was best able to classify subtle cognitive impairment from typical performance. RESULTS The NIH Toolbox formed one composite and exhibited the strongest within-battery alignment, while the Cogstate-C3 formed two distinct composites (Learning-Memory and Processing Speed-Attention). The NIH Toolbox and C3 Learning-Memory composites exhibited positive correlations with the PACC (ρ=0.49, p<0.001; ρ=0.58, p<0.001, respectively), but not the C3 Processing Speed-Attention composite, ρ=-0.18, p=0.22. The C3 Learning-Memory was the only composite that classified subtle cognitive impairment, and demonstrated the greatest sensitivity (62%) and specificity (81%) for that subtle cognitive impairment. CONCLUSIONS Preliminary findings suggest that the NIH Toolbox has the advantage of showing the strongest overall clustering and alignment with standardized paper-and-pencil tasks. By contrast, Learning-Memory tasks within the Cogstate-C3 battery have the greatest potential to identify cross-sectional, subtle cognitive impairment as defined by the PACC.
Collapse
Affiliation(s)
- R F Buckley
- Dorene M. Rentz, Harvard Medical School, Department of Neurology, Brigham and Women's Hospital, 60 Fenwood Road, Boston, MA 02115, Phone 617-732-8235,
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Rentz DM, Mormino EC, Papp KV, Johnson K, Sperling RA. F1‐04‐01: Longitudinal Peformance on the Preclinical Alzheimer’s Cognitive Composite (PACC) in Subjects with Biomarker‐Defined Preclincal ad. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Dorene M. Rentz
- Center for Alzheimer Research and Treatment, Brigham and Womens Hospital, Harvard Medical SchoolBostonMA USA
| | | | - Kate V. Papp
- Harvard Medical SchoolBostonMA USA
- Brigham and Women's HosptialBostonMA USA
| | - Keith Johnson
- Department of Radiology Division of Molecular Imaging and Nuclear Medicine Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
| | - Reisa A. Sperling
- Center for Alzheimer Research and Treatment, Brigham and Womens Hospital, Harvard Medical SchoolBostonMA USA
| |
Collapse
|
24
|
Papp KV, Mormino EC, Amariglio R, Sperling RA, Rentz DM, Johnson K, Schultz AP. O3‐09‐03: Associations between Amyloidosis and Longitudinal Cognitive Decline in Clinically Normal Older Adults. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Kate V. Papp
- Center for Alzheimer Research and Treatment Department of Neurology Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
- Harvard Medical SchoolBostonMA USA
| | | | - Rebecca Amariglio
- Harvard Medical SchoolBostonMA USA
- Center for Alzheimer Research and Treatment, Brigham and Womens Hospital, Harvard Medical SchoolBostonMA USA
| | - Reisa A. Sperling
- Harvard Medical SchoolBostonMA USA
- Massachusetts General HospitalCharlestownMA USA
- Center for Alzheimer Research and Treatment, Brigham and Womens Hospital, Harvard Medical SchoolBostonMA USA
| | - Dorene M. Rentz
- Center for Alzheimer Research and Treatment, Brigham and Womens Hospital, Harvard Medical SchoolBostonMA USA
| | - Keith Johnson
- Massachusetts General HospitalCharlestownMA USA
- Athinoula A. Martinos Center for Biomedical Imaging and the Department of Psychiatry Massachusetts General Hospital, Harvard Medical SchoolCharlestownMA USA
| | - Aaron P. Schultz
- Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging, Harvard Medical SchoolBostonMA USA
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical SchoolCharlestownMA USA
| |
Collapse
|
25
|
Munro CE, Donovan NJ, Amariglio R, Papp KV, Marshall GA, Rentz DM, Pascual-Leone A, Sperling RA, Vannini P. O4‐06‐06: The Impact of Anosognosia and Anosodiaphoria on the Prediction of Progression from Mild Cognitive Impairment to Alzheimer's Disease. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.642] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
| | - Nancy J. Donovan
- Harvard Medical SchoolBostonMA USA
- Brigham and Women's HospitalBostonMA USA
| | - Rebecca Amariglio
- Harvard Medical SchoolBostonMA USA
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | - Kate V. Papp
- Harvard Medical SchoolBostonMA USA
- Brigham and Women's HospitalBostonMA USA
- Brigham and Women's HospitalBostonMA USA
| | - Gad A. Marshall
- Harvard Medical SchoolBostonMA USA
- Department of Neurology Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
- Center for Alzheimer Research and Treatment Department of Neurology Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | - Dorene M. Rentz
- Brigham and Women's HospitalBostonMA USA
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
- Massachusetts General Hospital, Harvard Medical SchoolCharlestownMA USA
| | - Alvaro Pascual-Leone
- Berenson-Allen Center for Noninvasive Brain Stimulation Division of Cognitive Neurology Beth Israel Deaconess Medical Center, Harvard Medical SchoolBostonMA USA
| | - Reisa A. Sperling
- Massachusetts General HospitalCharlestownMA USA
- Harvard Medical SchoolBostonMA USA
- Brigham and Women's HospitalBostonMA USA
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
- Department of Neurology Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
| | - Patrizia Vannini
- Harvard Medical SchoolBostonMA USA
- Brigham and Women's HospitalBostonMA USA
- Center for Alzheimer Research and Treatment Department of Neurology Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
- Athinoula A. Martinos Center for Biomedical Imaging and the Department of Psychiatry Massachusetts General Hospital, Harvard Medical SchoolCharlestownMA USA
| |
Collapse
|
26
|
Papp KV, Mormino EC, Amariglio R, Schultz AP, Quiroz YT, Jaimes SY, Aghjayan SL, Munro CE, Kilpatrick EP, Johnson K, Sperling RA, Rentz DM. P3‐309: Profiles of Cognitive Decline Associated with Biomarker‐Defined Preclinical Stages of Alzheimer’s Disease. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.1973] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- Kate V. Papp
- Harvard Medical SchoolBostonMA USA
- Brigham and Women's HospitalBostonMA USA
| | | | - Rebecca Amariglio
- Harvard Medical SchoolBostonMA USA
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | - Aaron P. Schultz
- Harvard Medical SchoolBostonMA USA
- Massachusetts General Hospital and the Athinoula A. Martinos Center for Biomedical ImagingBostonMA USA
| | - Yakeel T. Quiroz
- Harvard Medical SchoolBostonMA USA
- Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
| | - Sehily Y. Jaimes
- Brigham and Women's HospitalBostonMA USA
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | | | | | | | - Keith Johnson
- Massachusetts General HospitalCharlestownMA USA
- Department of Neurology Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
- Athinoula A. Martinos Center for Biomedical Imaging and the Department of Psychiatry Massachusetts General Hospital, Harvard Medical SchoolCharlestownMA USA
| | - Reisa A. Sperling
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
- Department of Neurology Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical SchoolCharlestownMA USA
| | - Dorene M. Rentz
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
- Massachusetts General Hospital, Harvard Medical SchoolCharlestownMA USA
| |
Collapse
|
27
|
Jacobs HI, Schultz AP, Amariglio R, Hedden T, Papp KV, Perea RD, Rentz DM, Sepulcre J, Sperling RA, Johnson K. IC‐P‐185: The Effect of Tract‐Specific Loss of White Matter Connectivity on Cognitive Decline in Healthy Older Individuals Depends on Entorhinal T807 Binding. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Heidi I.L. Jacobs
- Massachusetts General Hospital, Athinoula A. Martinos Centre for Biomedical Imaging, Harvard Medical SchoolBostonMA USA
| | - Aaron P. Schultz
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical SchoolCharlestownMA USA
| | - Rebecca Amariglio
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | - Trey Hedden
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical SchoolCharlestownMA USA
| | - Kate V. Papp
- Center for Alzheimer Research and Treatment Department of Neurology Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | - Rodrigo D. Perea
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
| | - Dorene M. Rentz
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | - Jorge Sepulcre
- Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging, Harvard Medical SchoolBostonMA USA
| | - Reisa A. Sperling
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical SchoolCharlestownMA USA
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | - Keith Johnson
- Center for Alzheimer Research and Treatment Department of Neurology Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
- Department of Neurology Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
- Department of Radiology Division of Molecular Imaging and Nuclear Medicine Massachusetts General Hospital Harvard Medical SchoolBostonMA USA
- Athinoula A. Martinos Center for Biomedical Imaging and the Department of Psychiatry Massachusetts General Hospital, Harvard Medical SchoolCharlestownMA USA
| |
Collapse
|
28
|
Amariglio R, Mormino EC, Papp KV, Vannini P, Aghjayan SL, Marshall GA, Johnson K, Sperling RA, Rentz DM. P2‐341: Subjective Cognitive Decline Predicts Longitudinal Decline in those with Both Amyloidosis and Neurodegeneration. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.1471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Rebecca Amariglio
- Brigham and Women's HospitalBostonMA USA
- Massachusetts General Hospital, Harvard Medical SchoolCharlestownMA USA
| | | | - Kate V. Papp
- Harvard Medical SchoolBostonMA USA
- Brigham and Women's HosptialBostonMA USA
| | - Patrizia Vannini
- Brigham and Women's HospitalBostonMA USA
- Massachusetts General HospitalCharlestownMA USA
| | | | - Gad A. Marshall
- Department of Neurology Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
- Center for Alzheimer Research and Treatment Department of Neurology Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | - Keith Johnson
- Department of Neurology Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
- Center for Alzheimer Research and Treatment Department of Neurology Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
- Department of Radiology, Division of Molecular Imaging and Nuclear Medicine Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
| | - Reisa A. Sperling
- Department of Neurology Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
- Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical SchoolBostonMA USA
| | - Dorene M. Rentz
- Brigham and Women's HospitalBostonMA USA
- Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical SchoolBostonMA USA
| |
Collapse
|
29
|
Hanseeuw BJ, Mormino EC, Papp KV, Amariglio R, Chhatwal JP, Marshall GA, LaPoint MR, Jacobs HIL, Vannini P, Munro CE, McLaren D, Bark JS, Sepulcre J, Schultz AP, Betensky RA, Rentz DM, Sperling RA, Johnson K. O4‐07‐05: Pet Staging of Amyloidosis: Evidence that Amyloid Occurs First in Neocortex and Later in Striatum. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Bernard J. Hanseeuw
- Massachusetts General HospitalCharlestownMA USA
- Harvard Medical SchoolBostonMA USA
| | | | - Kate V. Papp
- Harvard Medical SchoolBostonMA USA
- Brigham and Women's HosptialBostonMA USA
| | | | - Jasmeer P. Chhatwal
- Massachusetts General HospitalCharlestownMA USA
- Harvard Medical SchoolBostonMA USA
| | - Gad A. Marshall
- Harvard Medical SchoolBostonMA USA
- Center for Alzheimer Research and Treatment Department of Neurology Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | | | - Heidi IL. Jacobs
- Massachusetts General Hospital, Athinoula A. Martinos Centre for Biomedical Imaging Harvard Medical SchoolBostonMA USA
| | - Patrizia Vannini
- Massachusetts General HospitalCharlestownMA USA
- Harvard Medical SchoolBostonMA USA
- Center for Alzheimer Research and Treatment Department of Neurology Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | | | | | | | - Jorge Sepulcre
- Massachusetts General HospitalCharlestownMA USA
- Harvard Medical SchoolBostonMA USA
| | | | | | - Dorene M. Rentz
- Massachusetts General Hospital, Harvard Medical SchoolCharlestownMA USA
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | - Reisa A. Sperling
- Massachusetts General HospitalCharlestownMA USA
- Harvard Medical SchoolBostonMA USA
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
| | - Keith Johnson
- Massachusetts General HospitalCharlestownMA USA
- Center for Alzheimer Research and Treatment Department of Neurology Brigham and Women’s Hospital, Harvard Medical SchoolBostonMA USA
- Department of Radiology Division of Molecular Imaging and Nuclear Medicine Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
| |
Collapse
|
30
|
Mormino EC, Papp KV, Schultz AP, Hanseeuw BJ, Munro CE, Jaimes SY, Meneide TF, Kilpatrick EP, Aghjayan SL, Jonas VH, Kirn D, Jackson JD, Amariglio R, Rentz DM, Sperling RA, Johnson K. O4‐01‐06: Ab+ Clinically Normal Participants with Elevated Tau Show Greatest Decline in the Preclinical Alzheimer’s Disease Cognitive Composite. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | - Dylan Kirn
- Massachusetts General HospitalBostonMA USA
| | | | - Rebecca Amariglio
- Center for Alzheimer Research and Treatment, Brigham and Womens Hospital, Harvard Medical SchoolBostonMA USA
| | - Dorene M. Rentz
- Brigham and Women's HospitalBostonMA USA
- Massachusetts General Hospital, Harvard Medical SchoolCharlestownMA USA
| | - Reisa A. Sperling
- Center for Alzheimer Research and Treatment, Brigham and Womens Hospital, Harvard Medical SchoolBostonMA USA
- Department of Neurology Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
| | - Keith Johnson
- Department of Radiology Division of Molecular Imaging and Nuclear Medicine Massachusetts General Hospital, Harvard Medical SchoolBostonMA USA
- Athinoula A. Martinos Center for Biomedical Imaging and the Department of Psychiatry Massachusetts General Hospital, Harvard Medical SchoolCharlestownMA USA
| |
Collapse
|